Showing results (61-70 of 112) with videos related to
Sort By:
Pageof 12
Frontiers in Oncology|September 5, 2025
Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor-related pneumonitis in lung cancer patientsFriederike Völter, Lukas Wehlte, Blerina Resuli, et al.EJNMMI Physics|February 9, 2023
Investigation of image-based lesion and kidney dosimetry protocols for <sup>177</sup>Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisitionSandra Resch, Sarah Takayama Fouladgar, Mathias Zacherl, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2020
<sup>18</sup>F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary resultsL M Mittlmeier, M Unterrainer, S Rodler, et al.Cancers|October 14, 2022
Can Radiomics Provide Additional Information in [<sup>18</sup>F]FET-Negative Gliomas?Katharina von Rohr, Marcus Unterrainer, Adrien Holzgreve, et al.Cancers|May 14, 2025
Comparison of the Hematotoxicity of PRRT with Lutathera<sup>®</sup> and Locally Manufactured <sup>177</sup>Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application IntervalsMarkus Hofmann, Sophie C Kunte, Marcus Unterrainer, et al.Clinical Nuclear Medicine|October 2, 2024
Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18 F-SiTATESophie C Kunte, Lena M Unterrainer, Wolfgang G Kunz, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 12, 2023
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerDirk Mehrens, Kristina K M Kramer, Lena M Unterrainer, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic settingMaximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 20, 2017
TSPO PET for glioma imaging using the novel ligand <sup>18</sup>F-GE-180: first results in patients with glioblastomaNathalie L Albert, M Unterrainer, D F Fleischmann, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2019
Biodistribution and first clinical results of <sup>18</sup>F-SiFAlin-TATE PET: a novel <sup>18</sup>F-labeled somatostatin analog for imaging of neuroendocrine tumorsHarun Ilhan, S Lindner, A Todica, et al.Pageof 12